Yahoo Finance • 14 days ago
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Intelligent B... Full story
Yahoo Finance • 2 months ago
* Intelligent Bio Solutions reports record monthly cartridge sales for July. * Shipped 519 boxes, representing around 12500 cartridges, and a 60% year-on-year. * A recent significant tender win has secured a multi-site, high-volume c... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-... Full story
Yahoo Finance • 2 months ago
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increas... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announce... Full story
Yahoo Finance • 2 months ago
* Intelligent Bio Solutions (NASDAQ:INBS [https://seekingalpha.com/symbol/INBS]) announced [https://seekingalpha.com/pr/20193193-intelligent-bio-solutions-announces-preliminary-fiscal-fourth-quarter-revenue-with-double] on Thursday preli... Full story
Yahoo Finance • 2 months ago
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through... Full story
Yahoo Finance • 2 months ago
Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday. Intelligent Bio Solutions is a medical technology company delivering intelligent, rap... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submissi... Full story
Yahoo Finance • 2 months ago
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secur... Full story
Yahoo Finance • 3 months ago
Data confirms Company’s ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INB... Full story
Yahoo Finance • 3 months ago
NEW YORK - Intelligent Bio Solutions Inc. (Nasdaq:INBS) announced Wednesday a new global distribution agreement with Texas-based SMARTOX to distribute its SmarTest Patch drug detection product in international markets outside the United St... Full story
Yahoo Finance • 3 months ago
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global... Full story
Yahoo Finance • 3 months ago
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition... Full story
Yahoo Finance • 3 months ago
Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap company with a market capitalization of $12.65 million, announced amendments to the employment agreements of its President and Chief Executive Officer, Harry Simeondis, and Chief Fi... Full story
Yahoo Finance • 4 months ago
NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap healthcare technology company with a market value of $12.3 million, is expanding its fingerprint-based drug screening technology across Scandinavia through its partnershi... Full story
Yahoo Finance • 4 months ago
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success... Full story
Yahoo Finance • 4 months ago
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed... Full story
Yahoo Finance • 4 months ago
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connec... Full story
Yahoo Finance • 5 months ago
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countr... Full story